0.8040EUR+7.92%Mkt Cap: 31.02M $P/E: —1d ago
Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbe…
Indicators:|
Key Statistics
Company
Market Cap31.02M $
Enterprise Value16.78M $
Revenue (TTM)983.70K $
Gross Profit-1.44M $
Net Income (TTM)-10.24M $
Revenue/Share0.0500 USD
Last Price0.8040 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees50
CountryFR
SectorConsumer Defensive
IndustryPackaged Foods
ISINFR0013254851
Valuation
P/E (Trailing)—
P/E (Forward)-10.05
PEG—
EV/EBITDA-1.68
EV/Revenue17.05
P/S31.54
P/B2.73
EPS (TTM)-0.46
EPS (Forward)-0.08
52W Range
0.535035% of range1.296
52W High1.296 EUR
52W Low0.5350 EUR
Profitability
Gross Margin-146.19%
Oper. Margin-844.06%
EBITDA Margin0.00%
Profit Margin-1040.55%
ROE-135.28%
ROA-65.45%
Growth
Revenue Growth305.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.74M $
CapEx (TTM)164.13K $
FCF Margin-517.15%
FCF Yield-16.40%
Net Debt-3.90M $
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.73
Current Ratio2.85
Quick Ratio2.22
Book Value/Sh0.2940 EUR
Cash/Share0.3670 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.228 EUR
Upside (mean)+177.1%
Target Range1.800 EUR – 2.655 EUR
€1.800+177.1% to mean€2.655
# Analysts2
Ownership
Shares Out.35.50M
Float22.95M
Insiders3.86%
Institutions1.57%
Technical
SMA 500.9804 (-18.0%)
SMA 2000.8771 (-8.3%)
Beta-0.20
S&P 52W Chg20.05%
Avg Vol (30d)177.49K
Avg Vol (10d)199.13K
Technical Indicators
RSI (14)35.8
MACD-0.0612
MACD Signal-0.0504
MACD Hist.-0.0107
BB Upper1.096 EUR
BB Middle0.9052 EUR
BB Lower0.7142 EUR
BB Width42.21%
ATR (14)0.0567 EUR
Vol Ratio (20d)1.06x